TransCode Therapeutics - SEC Filing
Por um escritor misterioso
Descrição
TransCode Therapeutics - Investor Relations
Cass Information Systems reports Firs
IPO Update: TransCode Therapeutics Pursues $25 Million IPO
TransCode Therapeutics Announces Equity Investment from White Lion
Small Biotechs Are Pulling Public Offerings, IPOs Amid 'Current
EDGAR Filing Documents for 0001104659-21-029169
TransCode Therapeutics - SEC Filing
Mainz Biomed to Showcase ColoAlert® a
TransCode Therapeutics Announces Public Offering of Common Stock
EDGAR Filing Documents for 0001104659-21-029169
TransCode Therapeutics - SEC Filing
de
por adulto (o preço varia de acordo com o tamanho do grupo)
